An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials